• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Introduction to Piperidin-2-ylmethanamine dihydrochloride (CAS No. 56098-52-3)

Piperidin-2-ylmethanamine dihydrochloride, a compound with the chemical identifier CAS No. 56098-52-3, is a significant molecule in the field of pharmaceutical chemistry and drug development. This compound, characterized by its piperidine ring and secondary amine functionality, has garnered attention due to its versatile applications in medicinal chemistry. The structural motif of Piperidin-2-ylmethanamine dihydrochloride makes it a valuable scaffold for designing novel therapeutic agents.

The piperidine moiety is a common pharmacophore in many bioactive molecules, contributing to their binding affinity and metabolic stability. In recent years, there has been a surge in research focused on developing new derivatives of piperidine-based compounds, particularly those that can modulate central nervous system (CNS) neurotransmitter systems. Piperidin-2-ylmethanamine dihydrochloride, with its unique structural features, has been explored as a potential lead compound in the synthesis of drugs targeting neurological disorders.

Recent studies have highlighted the compound's role in the development of drugs that interact with serotonin and dopamine receptors. These interactions are crucial for treating conditions such as depression, anxiety, and Parkinson's disease. The dihydrochloride salt form of Piperidin-2-ylmethanamine enhances its solubility and bioavailability, making it an attractive candidate for further pharmacological investigation.

One of the most compelling aspects of Piperidin-2-ylmethanamine dihydrochloride is its potential as a building block for more complex molecules. Medicinal chemists have leveraged its scaffold to create libraries of derivatives that can be screened for biological activity. High-throughput screening (HTS) techniques have been employed to identify compounds with enhanced efficacy and reduced side effects. This approach has led to the discovery of several promising candidates that are currently undergoing preclinical testing.

The synthesis of Piperidin-2-ylmethanamine dihydrochloride involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Advanced synthetic methodologies, such as transition metal-catalyzed cross-coupling reactions and asymmetric hydrogenation, have been utilized to improve the efficiency of the synthetic route. These techniques not only enhance the scalability of production but also allow for the introduction of diverse functional groups into the molecule.

In addition to its pharmaceutical applications, Piperidin-2-ylmethanamine dihydrochloride has shown promise in materials science and chemical biology. Its ability to act as a ligand in coordination chemistry has led to the development of new catalysts and sensors. Furthermore, its interaction with biological macromolecules has been studied to understand drug-receptor binding mechanisms better.

The future prospects for Piperidin-2-ylmethanamine dihydrochloride are vast and exciting. Ongoing research aims to explore its potential in treating a broader range of diseases, including cancer and inflammatory disorders. Innovations in computational chemistry and machine learning are being integrated into drug discovery pipelines to accelerate the identification of new therapeutic agents based on this scaffold.

Collaborative efforts between academia and industry are essential to translate these laboratory findings into clinical applications. By combining expertise in organic synthesis, pharmacology, and computational modeling, researchers can accelerate the development of next-generation drugs derived from Piperidin-2-ylmethanamine dihydrochloride.

In conclusion, Piperidin-2-ylmethanamine dihydrochloride represents a significant advancement in pharmaceutical chemistry. Its unique structural properties and versatile applications make it a cornerstone in the design of novel therapeutic agents. As research continues to uncover new possibilities for this compound, its impact on medicine and science is poised to grow even further.

• 22990-77-8(2-Piperidinemethanamine)
• 120990-88-7(ethyl[(piperidin-2-yl)methyl]amine)
• 54012-73-6(piperidin-3-amine)
• 1235439-19-6(Isopropylpiperidin-3-ylamine)
• 1250526-55-6(N-[(piperidin-2-yl)methyl]cyclopropanamine)
• 531-67-9(2-(2-piperidyl)piperidine)
• 1251083-96-1(N-Cyclopropylpiperidin-3-amine)
• 1249848-14-3(N-Ethylpiperidin-3-amine)
• 80918-66-7((S)-3-Piperidinamine)
• 127294-73-9((R)-Piperidin-3-amine)